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Effects of Carboxypeptidase E Overexpression on Insulin mRNA Levels,
Regulated Insulin Secretion, and Proinsulin Processing of Pituitary GH3 Cells
Transfected With a Furin-Cleavable Human Proinsulin cDNA
Luca Polastri,* Francesca Galbiati,* Franco Folli,† and Alberto M. Davalli*
*Department of Medicine and †Unit for Metabolic Diseases, San Raffaele Scientific Institute, Milan, Italy
We recently developed two rat pituitary GH3 cell clones engineered to secrete human insulin (InsGH3).
InsGH3 cells convert proinsulin into mature insulin, which is partially stored into a readily releasable pool
of secretory granules. The efficiency of these processes, however, is relatively low in these cells, either in
vitro or in vivo. This study was aimed at determining whether carboxypeptidase E (Cpe) overexpression can
increase proinsulin processing and regulated secretion by InsGH3 clones. Indeed, in its membrane-bound
form Cpe works as sorting receptor for the regulated secretory pathway of many hormones while, in its
soluble form, Cpe takes part to the late step of insulin maturation. We obtained two Cpe-overexpressing cell
lines from two different InsGH3 clones (InsGH3/C1 and C7). In the Cpe-overexpressing cell lines, derived
from InsGH3 of clone 1 (InsGH3/C1-HACpe), in which the membrane-bound form of exogenous Cpe is
accounted for by 90% of total Cpe immunoreactivity, we observed an increase in proinsulin gene expression,
and in basal and stimulated insulin secretion compared with the original clone. In contrast, in the Cpe-
overexpressing cell line derived from InsGH3 of clone 7 (InsGH3/C7-HACpe), where the exogenous mem-
brane-bound form was only 60% of total Cpe, we detected a decrease in basal insulin release and a modest,
albeit significant, increase in intracellular proinsulin processing. In conclusion, Cpe overexpression can in-
crease regulated insulin secretion and proinsulin processing in InsGH3 cells; however, such improvements
appear quantitatively and qualitatively modest.
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INTRODUCTION agents and can survive in vitro at extremely high den-
sity. This peculiar resistance to cell death signals has
We recently proposed bioengineered insulin-secreting been related to their naturally high levels of antiapop-
pituitary cells as potential β-cell surrogates for encapsu- totic Bcl-2 protein (12,16). Although proinsulin is pro-
lation-based diabetes cell therapy (5,16). Pituitary cells cessed to mature insulin by InsGH3 cells, this process is
are interesting because they have a regulated secretory not particularly efficient and mature insulin accounts for
pathway (RSP) of protein secretion (21) and, in contrast only 40% of total released proinsulin forms. Targeting
to pancreatic β-cells (22,24), are not recognized by cyto- of proinsulin transgene products to the RSP was con-
toxic antibodies present in sera of diabetic NOD mice firmed by immunofluorescence that showed the colocal-
(20). Moreover, insulin-secreting pituitary cells trans- ization of insulin with secretogranin II (a marker of reg-
planted into spontaneously diabetic NOD mice escape ulated secretion), and by the ability of InsGH3 cells to
the recurrence of autoimmune destruction and survive increase insulin release in response to an acute stimula-
indefinitely after implantation (14). tion. Moreover, implantation of InsGH3 cells into strep-
We previously developed two insulin-secreting GH3 tozotocin-induced diabetic mice reversed hyperglycemia
cell clones (InsGH3/C1 and InsGH3/C7) stably transfec- and induced the appearance of circulating human c-pep-
ted with a modified furin-cleavable human proinsulin tide, proinsulin, and insulin levels of about 9, 32, and 35
cDNA (7) placed under the control of the prolactin pro- pmol/L, respectively. However, uncontrolled graft growth
moter (5,16). We showed that InsGH3 cells are more and elevate constitutive insulin release by transplanted
resistant than pancreatic βTC3 cells to different cytotoxic InsGH3 cells induced hypoglycemia in the long term.
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Encapsulation, which represents a physical barrier against and, 24 h later, the cells were transfected with the plas-
mid by using Lipofectin (GIBCO/BRL) following theuncontrolled cell growth, may control tumorigenicity but
the only way to increase proinsulin processing and se- manufacturer’s instructions. After 3 weeks of culture,
cells resistant to 0.25 mg/ml of hygromycin (GIBCO/cretagogue-induced (regulated) secretion is to perform
further engineering of InsGH3 cells. BRL) were trypsinized, collected, and expanded as cell
lines (InsGH3/C1-HACpe and InsGH3/C7-HACpe). AllInsulin is synthesized into the rough endoplasmic
reticulum as a larger precursor (preproinsulin); preproin- experiments were performed between passages 2 and 15.
sulin is then transported to the trans-Golgi, where it seg- Northern Blot Analysis
regates into the vesicles of the RSP and where the endo-
The expression of human proinsulin, Cpe, and ribo-proteases PC1 and PC3 transform proinsulin into mature
somal 18S genes was analyzed in InsGH3 and InsGH3/insulin. Finally, secretory granules rich of mature insulin
HACpe cells. Total cellular RNA was prepared with the(>90%) are released by a Ca2+-dependent exocytotic pro-
RNAFAST isolation system (Biotecx Laboratories Inc.,cess (1,15,23). Protein aggregation and the presence of
Houston, TX) and Northern blot analysis was per-a sorting receptor are the two models proposed to ex-
formed. Twenty micrograms of total RNA from eachplain how proteins are selectively targeted to the RSP
sample was denaturated with formaldehyde, electropho-(1,15). The latter hypothesis is supported by the identifi-
resed on 1% denaturing agarose gel, and blotted to acation of a specific sorting signal motif in many prohor-
Hybond nylon membrane. Blots were hybridized withmones (2,3), and by the demonstration that the mem-
32P-labeled human modified insulin, ribosomal 18S, andbrane-bound form of carboxypeptidase E (Cpe) acts as
HindIII/XhoII fragment of rat Cpe cDNA (1.2 kb) probes.a sorting receptor (4). Moreover, in its soluble form, Cpe
Relative expression levels of proinsulin, Cpe, and ribo-participates to the last step of insulin processing by re-
somal 18S mRNA were determined by densitometricmoving basic residues from the C-terminal region of the
analysis.proinsulin molecule (15).
Therefore, we here explored whether Cpe overex- Western Blotting
pression may enhance regulated insulin secretion and Membrane-bound and soluble HACpe protein levelsproinsulin processing by InsGH3/C1 and C7 cell clones.
were measured in InsGH3/C1-HACpe and InsGH3/Our data indicate that when overexpression occurs by C7-HACpe cells by Western blotting by using anti-HA90% in its membrane-bound form, exogenous Cpe can
antibody (clone 12CA5, rabbit anti-mouse 1:1000, Roche
actually increase secretagogue-induced (regulated) insu- Diagnostics Corp. Indianapolis, IN). Membrane-boundlin secretion. Conversely, when exogenous Cpe expres-
and soluble forms were identified by the molecular
sion is only 60% in its membrane-bound form, the in-
weight (19).
crease in regulated insulin secretion does not occur but
proinsulin processing to mature insulin is slightly in- Insulin Assays
creased. Mature insulin content and release was measured by
IRI IMX kit (Abbot Laboratories, Tokyo, Japan), whichMATERIALS AND METHODS
recognized only mature insulin. Proinsulin and the other
Cells and Cell Culture split forms presented in cell lysates and released in the
Rat pituitary GH3 (American Type Culture Collec- media were measured by DAKO TOTAL proinsulin kit
tion) and InsGH3 clones were cultured in DMEM tissue (DAKO Diagnostics Ltd., Ely).
culture medium 25 mmol/L glucose supplemented with
Secretagogue-Induced Insulin Release10% fetal calf serum (FCS), 2 mmol/L glutamine, and
Secretagogue-induced mature insulin release by Ins-100 IU/ml streptomycin/penicillin (DMEM-c). Cultures
GH3 and InsGH3/HACpe cells was studied by static in-were performed under standard humidified culture con-
cubation. Cells were plated (1.6 × 105 cells per well) intoditions of 5% CO2 and 95% air at 37°C.
24-well plates and cultured overnight in standard tissue
Expression Vector and Transfection culture medium. The following day, cells were washed
in phosphate-buffered saline (PBS) and then incubatedThe rat carboxypeptidase E cDNA, fused in the
N-terminal region to the HA epitope tag of the human for 60 min in plain medium (without FCS), with the
addition of 10 µmol/L forskolin (FSK). After incuba-influenza virus (HACpe), was kindly provided by
Dr. Lloyd Friker (Albert Einstein College of Medicine, tion, supernatants were collected and stored at −20°C
until assayed for mature insulin as described. Cell ly-Bronx, NY). HACpe was cloned into pCEP4 expression
vector, containing the hygromycin resistance gene, un- sates were prepared for the measurement of total protein
and insulin content, and insulin release was expressed inder the control of the CMV promoter. About 5 × 105
InsGH3/C1 and C7 cells were plated onto six-well plates terms of protein content.
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Immunocytochemistry
InsGH3 and Cpe-overexpressing cells were fixed in
4% paraformaldehyde in PBS for 10 min. Cells were
blocked for 20 min in 20% normal goat serum in PBS
(PBS/NGS), then permeabilized for 10 min with 0.15%
Triton X-100 in PBS/NGS and incubated into anti-
insulin (mouse anti-human 1:100, Signet Laboratoires
Inc., Dedham, MA) at 37°C for 1.5 h. After three
washes with PBS, cells were incubated with secondary
antibody (1:2000) at room temperature for 1 h, washed
three times with PBS, and nuclei were marked with
DAPI (Sigma, St. Louis, MO, dil. 1:50 from 1 µg/ml in
ethanol) for 10 min. All experiments were analyzed with
a fluorescence microscope.
Statistical Analysis
Experiments were repeated at least three times. Data
were expressed as means ± SE. Statistical analysis was
performed using the unpaired Student’s t-test. Statistical
significance was considered at p < 0.05.
RESULTS
Development of InsGH3/HACpe Lines and
HACpe Distribution
After transfection and selection, hygromicin-resistent
cells of clone 1 and clone 7 were pooled to develop the
InsGH3/C1-HACpe and InsGH3/C7-HACpe lines. As
shown in Figure 1, Cpe overexpression in these lines
was confirmed at different passages by Northern Blot
analysis. Compared with clones 1 and 7, which showed
a similar level of endogenous Cpe (Fig. 1), InsGH3/
C1-HACpe and InsGH3/C7-HACpe showed a signifi-
cant increase in Cpe mRNA levels of about three- and
Figure 1. (Top) A representative Northern Blot showing car-sixfold compared with untrasfected cells, respectively.
boxypeptidase E gene expression in InsGH3/HACpe of bothThe presence of HACpe in transfected cells was con-
lines compared with their original InsGH3 cell clones. (Bot-firmed also with Western blot experiments (Fig. 2, upper tom) Densitometric analysis of five different experiments:
panel). Two bands of approximate molecular weight of Cpe mRNA levels were threefold higher in InsGH3/C1-
50 and 55 kDa were identified. Accordingly with the HACpe than in InsGH3/C1 and sixfold higher in InsGH3/C7-
HACpe than in InsGH3/C7. Data are means of at least threeprevious findings (19), these bands corresponded to the
different experiments ± SE. *p < 0.05. †p < 0.02.full-length membrane-bound (upper band) and truncated
soluble (lower band) forms of Cpe. To assess the rela-
tive distribution of exogenous Cpe in its two form, the
pared with untrasfected clone 7. Conversely, no differ-percentage of membrane-bound versus soluble form was
ences were found after Cpe overexpression in clone 1.analyzed at the densitometer (Fig. 2, lower panel). In
InsGH3/C1-HACpe and InsGH3/C7-HACpe revealedInsGH3/C1-HACpe, more than 90% of HACpe immu-
a diverse response in basal insulin release after Cpenoreactivity was localized in the membrane-bound form,
overexpression. Indeed, release of mature insulin waswhile in Ins GH3/C7-HACpe cells exogenous Cpe was
markedly increased in clone 1 (about 195% of untransfe-localized to about 60% in the membrane-bound form
cted cells), while it decreased (57% of untransfectedand 40% in the soluble form.
cells) in clone 7 (Table 1).
Basal Insulin Content and Release in
(Pro)Insulin ProcessingCpe-Overexpressing Lines
As shown in Table 1, InsGH3/C7-HACpe showed a The percentage of mature insulin in media and extract
of InsGH3/HACpe lines was measured and comparedsignificant decrease in mature insulin content when com-
806 POLASTRI ET AL.
Figure 2. (Top) a representative Western blot where cell proteins were immunoblotted with an
antibody against HA. Transfected cells showed two bands corresponding to full-length membrane-
bound (upper band, molecular weight 55 kDa) and truncated soluble form (lower band, molecular
weight 50 kDa) of Cpe, respectively. (Bottom) In InsGH3/C1-HACpe more than 90% of total
HACpe immunoreactivity was in the membrane-bound form. Conversely, only 60% of exogenous
Cpe was membrane bound in InsGH3/C7-HACpe cells. Data are means ± SE of three independent
experiments. *p < 0.05.
with those of original clones (Table 2). A significant when compared with untransfected InsGH3/C1). Con-
versely, FSK-stimulated insulin release did not changeincrease in mature insulin was detected in InsGH3/
C7-HACpe extract (from 51% to 66%). In contrast, no in InsGH3/C7-HACpe.
differences were observed in the percentage of mature
Immunocytochemistry Analysisinsulin secretion by Cpe-overexpressing InsGH3 cells
InsGH3/C1 cells transfected with Cpe showed a cyto-when compared with untransfected controls.
plasmic pattern of insulin immunoreactivity slightly
Forskolin-Induced Insulin Release different from control cells (Fig. 4). Indeed, insulin im-
munoreactivity in InsGH3/C1-HACpe appeared moreIn InsGH3 cells of both clones, FSK induced a dose-
dependent increase in insulin secretion that was maximal granular and mainly localized under the plasma mem-
brane than in InsGH3/C1 cells. No difference was notedat 10 µmol/L (16). As shown in Figure 3, after Cpe
overexpression the insulin response to FSK increased between InsGH3/C7 and InsGH3/C7-HACpe cells (data
not shown).further in InsGH3/C1-HACpe (about 50% increase
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Table 1. Mature Insulin Content and Basal Insulin Release in InsGH3 and InsGH3/HACpe
Cells, Expressed in Terms of Protein Content and as Percentage of Untransfected Control
Cells (Arbitrarily Assigned at 100%)
Content Release
% of % of
µU/µg Untransfected µU/µg Untransfected
of Protein Cells of Protein Cells
InsGH3/C1 0.17 ± 0.01 100 ± 0 3.2 ± 0.3 100 ± 0
InsGH3/C1-HACpe 0.14 ± 0.01 84 ± 11 6.0 ± 1.1† 195 ± 19†
InsGH3/C7 0.73 ± 0.06 100 ± 0 4.0 ± 0.2 100 ± 0
InsGH3/C7-HACpe 0.47 ± 0.05* 64 ± 11* 2.3 ± 0.08† 57 ± 3†
Insulin content was significantly lower in InsGH3/C7-HACpe than in untransfected InsGH3/C7 cells,
while in InsGH3/C1-HACpe cells it remained similar to their control cells (InsGH3/C1). Basal insulin
release increased significantly in Cpe-overexpressing cells of clone 1 (InsGH3/C1-HACpe) when com-
pared with their control cells. In contrast, InsGH3/C7-HACpe cells showed a significant decrease in
insulin secretion. Data are means ± SE of 7 experiments.
*p < 0.05 vs. control.
†p < 0.01 vs. control.
Human Proinsulin mRNA Levels matic activity and binds prohormomes such as proinsu-
lin, proenkephalin, and POMC in a first-order kineticsCpe overexpression did not induced any significant
similar to that of enzyme–substrate interaction (4). Themodification in proinsulin mRNA levels of Cpe-overex-
prohormone binding domain is distinct from the cata-pressing cells derived from clone 7. In contrast, proinsu-
lytic domain and becomes accessible only when Cpe islin mRNA levels were significantly higher in InsGH3/
bound to the membranes of the trans-Golgi network orC1-HACpe cells than in their untransfected control cells
the secretory vesicles (26). Moreover, the binding of(Fig. 5).
Cpe with the cholesterol-glycolipid raft is necessary for
DISCUSSION its sorting receptor function (6).
Previous reports have clearly shown the fundamentalIn β-cells and neuroendocrine cells, Cpe is present in
a membrane-bound form, localized on the trans-Golgi role of Cpe in the processing of the prehormones in their
and secretory vesicle membranes, and in a soluble form. active forms. Neuro-2a cells, in which Cpe expression
The latter derives from the proteolytic cleavage of the was completely abolished by antisense technology (Neuro-
C-terminal region, which is essential for the binding of 2a Cpe−/− cells), secrete completely unprocessed proen-
Cpe to the membranes (15,17). The soluble form of Cpe kephalin via the constitutive pathway (4,19). Lack of
is an enzymatically active endoprotease (11,15,23), Cpe activity was studied also in Cpefat mice, which have
while the membrane-bound form does not have enzy- a single point mutation in the Cpe gene that leads to the
transcription of an enzymatically inactive protein. The
phenotype of these mice is characterized by obesity, in-
Table 2. Percentage of Mature Over Total Immunoreactive fertility, and a diabetic syndrome consequent to the re-
Insulin in Extracts and Media of InsGH3 and InsGH3/HACpe lease of unprocessed proinsulin, which has a poor
Cells biological activity (18). However, the observation that
chromogranin A is correctly sorted into the regulatedExtracts Media
secretory pathway (RSP) in Neuro-2a Cpe−/− cells (19),
InsGH3/C1 52 ± 7 30 ± 7 and that β-cell lines derived from Cpefat mice secrete
InsGH3/C1-HACpe 47 ± 6 30 ± 9 unprocessed proinsulin but in a regulated manner (25),
InsGH3/C7 51 ± 5 26 ± 6
suggest that Cpe may be not strictly necessary for hor-InsGH3/C7-HACpe 66 ± 9* 33 ± 10
mone sorting to the RSP.
A significant increase in mature insulin content was detected in Ins- We developed two Cpe-overexpressing lines, derived
GH3/C7-HACpe cells, while the content of mature insulin released in from the InsGH3/C1 and InsGH3/C7 clones. In resultant
the media remained unchanged. No differences were found in InsGH3/
InsGH3/C1-HACpe and InsGH3/C7-HACpe cell lines,C1 clone before and after Cpe overexpression. Data are means ± SE
of 5 independent experiments. Cpe mRNA levels were about three- and sixfold higher
*p < 0.05 vs. control. than in their original untransfected clones, respectively
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Figure 3. Secretagogue-induced (regulated) insulin release (normalized in terms of insulin content
and expressed as percentage of basal release) by untransfected and Cpe-overexpressing InsGH3
cells in response to an acute stimulation with FSK. After 1-h incubation, insulin response to FSK
was significantly higher in InsGH3/C1-HACpe than InsGH3/C1 cells (*p < 0.02), while no differ-
ences were found in the InsGH3/C7 cells.
(Fig. 1). As previously described to occur for the proin- levels, which were similar in InsGH3/C7 cells before
and after Cpe overexpression. Therefore, reduced insulinsulin gene (16), exogenous Cpe gene was transcribed
more efficiently in InsGH3/C7 than in InsGH3/C1. biosynthesis must have occurred at the posttranscrip-
tional level, probably as a result of the increased car-The effect of Cpe overexpression in InsGH3 cells
varied depending on the relative distribution of its solu- boxypeptidase activity present in the cell. Indeed, the
extremely high levels of enzymatically active form ofble and membrane-bound form of protein. In InsGH3/
C7-HACpe cells, 60% of total Cpe immunoreactivity Cpe present in these cells could react with other mole-
cules and interfere with the normal proinsulin biosyn-was detected in its membrane-bound form and only 40%
in its soluble form (Fig. 2). This situation resembles the thesis.
In the other Cpe-overexpressing cell line (InsGH3/endogenous distribution of Cpe in AtT20 cells (9), and
suggests that the membrane-bound/soluble Cpe ratio re- C1-HACpe), exogenous Cpe was prevalently expressed
in its membrane-bound form (90% of total HACpe im-mained unaffected in InsGH3/C7-HACpe cells. Perhaps
this is the reason why sixfold higher Cpe mRNA levels munoreactivity) (Fig. 2). Proinsulin processing was un-
changed in InsGH3/C1-HACpe (Table 2), which showeddid not induce any changes in regulated insulin secretion
by these cells. Instead, InsGH3/C7-HACpe cells showed a significant increase in basal (Table 1) and in regulated
(FSK-induced) mature insulin release (Fig. 3). The higha significant increase in intracellular proinsulin process-
ing (Table 2) compared with the original. Indeed, it basal release of insulin by InsGH3/C1-HACpe cell line
might be partially explained by the higher level of ex-should be noted that all the other forms of unprocessed
proinsulin decreased more dramatically in InsGH3/C7- pression of the proinsulin gene, observed in these cells,
compared with their untransfected controls (Fig. 5). AsHACpe, because the ratio between mature insulin over
total immunoreactive insulin increased significantly in already stated, FSK-induced (regulated) insulin release
also increased significantly in InsGH3/C1-HACpe (Fig.this cells line (Table 2). Nevertheless, the increase in
percentage of mature insulin in extract of InsGH3/C7- 3). Perhaps in these cells, Cpe overexpression, by in-
creasing its membrane-bound form, has more efficientlyHACpe indicates that a modest increase in proinsulin
processing must have occurred in these cells. It should targeted insulin into the RSP and in the secretory gran-
ules. The evidence that in InsGH3/C1-HACpe cells in-be noted, however, that the efficiency of proinsulin pro-
cessing was significantly higher in wild-type GH3 cells sulin immunoreactivity appears more granular compared
with their original clone (Fig. 4) supports this hypothe-cotransfected with proinsulin and the β-cell-specific en-
doproteases PC1 and PC3 (13). sis. However, ultrastructural studies showed that the
pool of secretory granules was not quantitatively increasedThe decrease in total immunoreactive insulin forms
cannot be explained by a decrease in proinsulin mRNA in InsGH3/C1-HACpe (data not shown). Immunoelec-
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Figure 4. Insulin immunostaining in InsGH3/C1 and InsGH3/C1-HACpe cells. Compared with
InsGH3/C1, in Cpe-overexpressing cells insulin imunoreactivity appears more granular and less
abundant.
tromicroscopy with antibodies against insulin (or proin- i) insulin mRNA levels, ii) basal and regulated insulin
secretion, and iii) proinsulin processing. The effects ofsulin) was not performed in this study. Therefore, we
cannot exclude that an increase in mature insulin content Cpe overexpression were related to the subcellular local-
ization of the exogenous Cpe protein. The increase inwould have occurred in the granules of these cells. It is
also possible that exogenous membrane-bound Cpe, by the membrane-bound form augmented regulated secre-
tion, while the increase in the soluble form improvedfacilitating the translocation of insulin from the trans-
Golgi to the granules (accordingly to the receptor-medi- proinsulin processing to mature insulin. However, albeit
statistically significant, these effects were of small mag-ated sorting model), might accelerate the process of
granule formation and fusion to the plasma membrane, nitude, probably because endogenous Cpe is already
abundantly expressed in neuroendocrine cells. Otherthereby decreasing the half-life of the granules in the
cells. strategies might therefore be explored to render the insu-
lin secretory machinery of pituitary GH3 cells more sim-In conclusion, Cpe overexpression into insulin-secre-
ting pituitary GH3 cells (InsGH3) caused an increase in: ilar to that of the pancreatic β-cell.
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Figure 5. (Top) A representative Northern blot that depicts proinsulin gene expression in mouse
insulinoma βTC3, wild-type (WT) GH3 cells, InsGH3 clone 1 and 7, and the respective InsGH3/
HACpe cell lines. Proinsulin mRNA was higher in InsGH3 and in InsGH3/HACpe than in βTC3
cells and was absent in GH3 WT. (Bottom) Densitometric analysis of four different experiments
(insulin mRNA level of untransfected clones were arbitrary assigned to 100%). InsGH3/C1-HACpe
cells show a significant increase in insulin gene expression compared with untransfected InsGH3/
C1 cells (*p < 0.01). In contrast, no differences were detected between InsGH3/C7 and InsGH3/
C7-HACpe cells.
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